Metabolic and Toxic Myelopathies

Area of Science:

• Neurology
• Toxicology
• Metabolic Disorders

Background:

• Metabolic and toxic myelopathies are significant causes of morbidity.
• These conditions necessitate a high index of suspicion for accurate diagnosis.

Purpose of the Study:

• To describe the clinical presentation, diagnostic investigations, and treatment of metabolic and toxic myelopathies.
• To highlight the importance of early recognition and intervention.

Main Methods:

• Review of clinical presentations.
• Analysis of diagnostic investigations.
• Evaluation of treatment strategies for metabolic and toxic myelopathies.

Main Results:

• Metabolic myelopathies (e.g., vitamin B12, folate, copper, vitamin E deficiencies) are often preventable and treatable with supplementation.
• Toxic myelopathies (e.g., from medical interventions, dietary toxins, drugs of abuse) frequently lead to permanent deficits.
• Hepatic dysfunction-related toxic myelopathy may be reversible with early intervention; nitrous oxide myelopathy responds to vitamin B12 and exposure cessation.

Conclusions:

• Prompt diagnosis and management are critical for improving outcomes in metabolic myelopathy.
• Avoiding or mitigating exposure to causative agents is essential in toxic myelopathy.
• High clinical suspicion is paramount for diagnosing these myelopathies.